We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $8.34B
1-Year Est. Return 165.53%
This Fund
S&P 500
This Quarter Est. Return
+77.9%
1 Year Est. Return
+165.53%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.34B
AUM Growth
+$2.35B
Cap. Flow
-$42M
Cap. Flow %
-0.5%
Top 10 Hldgs %
46.57%
Holding
644
New
20
Increased
132
Reduced
424
Closed
57

Top Buys

Rank Stock Value
1
INIO
INNIO N.V.
INIO
+$177M
2
AMD icon
Advanced Micro Devices
AMD
+$119M
3
FORM icon
FormFactor
FORM
+$101M
4
CBRS
Cerebras Systems
CBRS
+$70.1M
5
ONTO icon
Onto Innovation
ONTO
+$64.5M

Top Sells

Rank Stock Value
1
TSEM icon
Tower Semiconductor
TSEM
+$220M
2
LITE icon
Lumentum
LITE
+$219M
3
TSLA icon
Tesla
TSLA
+$50.1M
4
CIEN icon
Ciena
CIEN
+$43.3M
5
MSFT icon
Microsoft
MSFT
+$42.6M

Sector Composition

Rank Sector Weight
1 Technology 66.11%
2 Communication Services 9.64%
3 Consumer Discretionary 8.42%
4 Industrials 4.35%
5 Healthcare 4.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SUI icon
276
Sun Communities
SUI
$14.5B
$198K ﹤0.01%
1,651
-242
-13% -$30.3K
DOC icon
277
Healthpeak Properties
DOC
$14.2B
$196K ﹤0.01%
9,171
-1,332
-13% -$24.9K
HALO icon
278
Halozyme
HALO
$12.5B
$196K ﹤0.01%
2,500
-141
-5% -$9.61K
ONC
279
BeOne Medicines Ltd
ONC
$40.5B
$194K ﹤0.01%
680
-27
-4% -$7.96K
NUVL
280
DELISTED
Nuvalent
NUVL
$191K ﹤0.01%
1,550
-72
-4% -$7.74K
OHI icon
281
Omega Healthcare
OHI
$14.1B
$191K ﹤0.01%
3,998
-461
-10% -$21.4K
IBRX icon
282
ImmunityBio
IBRX
$8.56B
$190K ﹤0.01%
21,749
-371
-2% -$2.81K
CVI icon
283
CVR Energy
CVI
$4.47B
$189K ﹤0.01%
6,862
-2,862
-29% -$90.9K
ALKS icon
284
Alkermes
ALKS
$7.73B
$185K ﹤0.01%
3,528
-181
-5% -$7.07K
DEC
285
Diversified Energy Company
DEC
$1.09B
$182K ﹤0.01%
+13,162
New +$199K
VEEV icon
286
Veeva Systems
VEEV
$44.5B
$177K ﹤0.01%
+1,000
New +$165K
PCVX icon
287
Vaxcyte
PCVX
$9.1B
$177K ﹤0.01%
3,048
+108
+4% +$5.87K
REG icon
288
Regency Centers
REG
$13.8B
$176K ﹤0.01%
2,201
-407
-16% -$32K
ABVX
289
Abivax
ABVX
$10B
$174K ﹤0.01%
1,302
-24
-2% -$2.72K
IMVT icon
290
Immunovant
IMVT
$8.11B
$166K ﹤0.01%
4,308
+372
+9% +$11.3K
PTGX icon
291
Protagonist Therapeutics
PTGX
$9.43B
$166K ﹤0.01%
1,353
-51
-4% -$5.33K
RYTM icon
292
Rhythm Pharmaceuticals
RYTM
$7.07B
$161K ﹤0.01%
1,448
-50
-3% -$4.52K
GLPI icon
293
Gaming and Leisure Properties
GLPI
$12.2B
$161K ﹤0.01%
3,609
-669
-16% -$31.3K
ELS icon
294
Equity Lifestyle Properties
ELS
$12.1B
$160K ﹤0.01%
2,476
-306
-11% -$19.3K
UDR icon
295
UDR
UDR
$11.7B
$156K ﹤0.01%
3,906
-852
-18% -$31.5K
APGE
296
DELISTED
Apogee Therapeutics
APGE
$154K ﹤0.01%
1,163
-69
-6% -$6.22K
MIRM icon
297
Mirum Pharmaceuticals
MIRM
$6.15B
$150K ﹤0.01%
1,280
+125
+11% +$12.6K
SYRE icon
298
Spyre Therapeutics
SYRE
$7.85B
$148K ﹤0.01%
1,664
-79
-5% -$5.76K
CPT icon
299
Camden Property Trust
CPT
$12.2B
$147K ﹤0.01%
1,287
-329
-20% -$35.1K
EGP icon
300
EastGroup Properties
EGP
$10.7B
$146K ﹤0.01%
723
-85
-11% -$17K
10 11
12
13 14

Similar funds

GLF
Groupe la Francaise Paris, France $8.31B AUM 37.53% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
MWM
Modern Wealth Management Lenexa, Kansas $8.4B AUM 21.02% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
OCA
OpenArc Corporate Advisory Atlanta, Georgia $8.41B AUM

GF Fund Management's Q2 2026 Portfolio in Review

As of Q2 2026, GF Fund Management held 644 positions worth $8.34B, up 39% from $5.98B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

GF Fund Management's Q2 2026 filing shows 20 new, 132 increased, 424 reduced and 57 closed positions. Its largest new stake was INNIO N.V.: 4,970,000 shares worth $197M. The largest sale was Tower Semiconductor, an estimated $220M.

By sector, the portfolio is most concentrated in Technology at 66% of assets, up from 54% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q2 2026 buy was INNIO N.V.: 4,970,000 shares worth $197M.
  • GF Fund Management added most to Advanced Micro Devices in Q2 2026, an estimated $119M increase.
  • GF Fund Management's biggest Q2 2026 reduction was Tower Semiconductor, cutting an estimated $220M.
  • GF Fund Management fully exited Coherent in Q2 2026, selling an estimated $23.3M.
  • GF Fund Management's ten largest holdings make up 47% of its $8.34B portfolio in Q2 2026.
  • GF Fund Management opened 20 new positions and closed 57 in Q2 2026.
  • GF Fund Management's portfolio value rose 39% quarter-over-quarter to $8.34B.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.